Literature DB >> 9688067

Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

P Johansen1, Y Men, R Audran, G Corradin, H P Merkle, B Gander.   

Abstract

PURPOSE: Tetanus toxoid (Ttxd) encapsulated in polyester microspheres (MS) for single injection immunization have so far given pulsatile in vitro release and strong immune response in animals, but no boosting effect. This has been ascribed to insufficient toxoid stability within the MS exposed to in vivo conditions over a prolonged time period. This study examined the effect of co-encapsulated putative stabilizing additives.
METHODS: Two different Ttxd were encapsulated in poly(D,L-lactic-co-glycolic acid) (PLGA 50:50) and poly(D,L-lactic acid) (PLA) MS by spray-drying. The influence of co-encapsulated additives on toxoid stability, loading in and release from the MS, was studied by fluorimetry and ELISA.
RESULTS: Co-encapsulated albumin, trehalose and gamma-hydroxypropyl cyclodextrin all improved the toxoid encapsulation efficiency in PLGA 50:50 MS. Albumin increased the encapsulation efficiency of antigenic Ttxd by one to two orders of magnitude. Further, with albumin or a mixture of albumin and trehalose ELISA responsive Ttxd was released over 1-2 months following a pulsatile pattern.
CONCLUSIONS: Optimized Ttxd containing MS may be valuable for a single-dose vaccine delivery system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688067     DOI: 10.1023/a:1011998615267

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.

Authors:  D K Xing; K McLellan; M J Corbel; D Sesardic
Journal:  Biologicals       Date:  1996-03       Impact factor: 1.856

2.  Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen.

Authors:  G F Kersten; D Donders; A Akkermans; E C Beuvery
Journal:  Vaccine       Date:  1996-12       Impact factor: 3.641

3.  Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.

Authors:  Y Men; B Gander; H P Merkle; G Corradin
Journal:  Vaccine       Date:  1996-10       Impact factor: 3.641

4.  Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.

Authors:  R K Gupta; A C Chang; P Griffin; R Rivera; Y Y Guo; G R Siber
Journal:  Vaccine       Date:  1997 Apr-May       Impact factor: 3.641

Review 5.  Protein--solvent interactions in pharmaceutical formulations.

Authors:  T Arakawa; Y Kita; J F Carpenter
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

6.  Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.

Authors:  S P Schwendeman; H R Costantino; R K Gupta; G R Siber; A M Klibanov; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability.

Authors:  P Johansen; H P Merkle; B Gander
Journal:  Biochim Biophys Acta       Date:  1998-10-23

8.  Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs.

Authors:  A J Almeida; H O Alpar; M R Brown
Journal:  J Pharm Pharmacol       Date:  1993-03       Impact factor: 3.765

9.  Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.

Authors:  A C Chang; R K Gupta
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

10.  Thermostabilization of live virus vaccines by heavy water (D2O).

Authors:  R Wu; M M Georgescu; F Delpeyroux; S Guillot; J Balanant; K Simpson; R Crainic
Journal:  Vaccine       Date:  1995-08       Impact factor: 3.641

View more
  19 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Effect of excipients on PLGA film degradation and the stability of an incorporated peptide.

Authors:  M L Houchin; S A Neuenswander; E M Topp
Journal:  J Control Release       Date:  2006-12-01       Impact factor: 9.776

Review 3.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

4.  Stability studies of microparticulate system with piroxicam as model drug.

Authors:  Shivanand Puthli; Pradeep R Vavia
Journal:  AAPS PharmSciTech       Date:  2009-07-01       Impact factor: 3.246

5.  On technological and immunological benefits of multivalent single-injection microsphere vaccines.

Authors:  Gérard Boehm; Marisa Peyre; Dorothea Sesardic; Rachel J Huskisson; Fatme Mawas; Alexandra Douglas; Dorothy Xing; Hans P Merkle; Bruno Gander; Pål Johansen
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

6.  Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives.

Authors:  G Zhu; S P Schwendeman
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

7.  Hollow Microparticles as a Superior Delivery System over Solid Microparticles for the Encapsulation of Peptides.

Authors:  Sharad Kharel; Archana Gautam; Andreas Dickescheid; Say Chye Joachim Loo
Journal:  Pharm Res       Date:  2018-08-02       Impact factor: 4.200

8.  Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement.

Authors:  Ingrid J Castellanos; Kai Griebenow
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 9.  Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances.

Authors:  Fei Wu; Tuo Jin
Journal:  AAPS PharmSciTech       Date:  2008-12-16       Impact factor: 3.246

10.  Key parameters affecting the initial leaky effect of hemoglobin-loaded nanoparticles as blood substitutes.

Authors:  Xiaolan Zhang; Changsheng Liu; Yuan Yuan; Shiyu Zhang; Xiaoqian Shan; Yan Sheng; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2008-01-25       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.